Related references
Note: Only part of the references are listed.St. Jude Cloud: A Pediatric Cancer Genomic Data-Sharing Ecosystem
Clay McLeod et al.
CANCER DISCOVERY (2021)
Mechanisms of Sensitivity and Resistance to CDK4/6 Inhibition
Monica Alvarez-Fernandez et al.
CANCER CELL (2020)
Efficient low-cost chromatin profiling with CUT&Tag
Hatice S. Kaya-Okur et al.
NATURE PROTOCOLS (2020)
Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastoma
Konstantin Helmsauer et al.
NATURE COMMUNICATIONS (2020)
The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism
Gerta Hoxhaj et al.
NATURE REVIEWS CANCER (2020)
Oncogenic KRAS Sensitizes Lung Adenocarcinoma to GSK-J4-Induced Metabolic and Oxidative Stress
Beom-Jin Hong et al.
CANCER RESEARCH (2019)
BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells
David N. Debruyne et al.
NATURE (2019)
CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2
Liying Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Identification of H3K4me1-associated proteins at mammalian enhancers
Andrea Local et al.
NATURE GENETICS (2018)
CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought
Mary E. Klein et al.
CANCER CELL (2018)
Histone H3 lysine 4 monomethylation modulates long-range chromatin interactions at enhancers
Jian Yan et al.
CELL RESEARCH (2018)
Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma
Rhamy Zeid et al.
NATURE GENETICS (2018)
Lineage specific transcription factors and epigenetic regulators mediate TGFβ-dependent enhancer activation
Raquel Fueyo et al.
NUCLEIC ACIDS RESEARCH (2018)
EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications
Zhenghao Li et al.
ONCOGENE (2018)
Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma
Timothy L. Lochmann et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations
Alexandra B. Keenan et al.
CELL SYSTEMS (2018)
Non-canonical functions of the RB protein in cancer
Frederick A. Dick et al.
NATURE REVIEWS CANCER (2018)
Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs
Rohit Mathur et al.
HAEMATOLOGICA (2017)
Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs
Rohit Mathur et al.
HAEMATOLOGICA (2017)
KDM6B modulates MAPK pathway mediating multiple myeloma cell growth and survival
H. Ohguchi et al.
LEUKEMIA (2017)
Complex multi-enhancer contacts captured by genome architecture mapping
Robert A. Beagrie et al.
NATURE (2017)
Inhibitor of H3K27 demethylase JMJD3/UTX GSK-J4 is a potential therapeutic option for castration resistant prostate cancer
Viacheslav M. Morozov et al.
ONCOTARGET (2017)
Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors
Maithili P. Dalvi et al.
CELL REPORTS (2017)
An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites
Peter J. Skene et al.
ELIFE (2017)
Regulation of the JMJD3 (KDM6B) histone demethylase in glioblastoma stem cells by STAT3
Maureen M. Sherry-Lynes et al.
PLOS ONE (2017)
Targeting Histone Demethylases in MYC-Driven Neuroblastomas with Ciclopirox
Jun Yang et al.
CANCER RESEARCH (2017)
Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations
Kristopher R. Bosse et al.
CANCER (2016)
Correlating chemical sensitivity and basal gene expression reveals mechanism of action
Matthew G. Rees et al.
NATURE CHEMICAL BIOLOGY (2016)
Targeting CDK4 and CDK6: From Discovery to Therapy
Charles J. Sherr et al.
CANCER DISCOVERY (2016)
Aberrant JMJD3 Expression Upregulates Slug to Promote Migration, Invasion, and Stem Cell-Like Behaviors in Hepatocellular Carcinoma
Bo Tang et al.
CANCER RESEARCH (2016)
Histone demethylases in physiology and cancer: a tale of two enzymes, JMJD3 and UTX
Kelly Marie Arcipowski et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2016)
RB1: a prototype tumor suppressor and an enigma
Nicholas J. Dyson
GENES & DEVELOPMENT (2016)
Structural analysis of human KDM5B guides histone demethylase inhibitor development
Catrine Johansson et al.
NATURE CHEMICAL BIOLOGY (2016)
deepTools2: a next generation web server for deep-sequencing data analysis
Fidel Ramirez et al.
NUCLEIC ACIDS RESEARCH (2016)
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
Maxim V. Kuleshov et al.
NUCLEIC ACIDS RESEARCH (2016)
Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM
Alan S. L. Wong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Neuroblastoma
Katherine K. Matthay et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder Cancer
Se-Ra Lee et al.
CLINICAL CANCER RESEARCH (2015)
The Role of Histone Demethylase KDM4B in Myc Signaling in Neuroblastoma
Jun Yang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
What are super-enhancers?
Sebastian Pott et al.
NATURE GENETICS (2015)
Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset
Brinton Seashore-Ludlow et al.
CANCER DISCOVERY (2015)
The Role of Histone Demethylase KDM4B in Myc Signaling in Neuroblastoma
Jun Yang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
UTX and MLL4 Coordinately Regulate Transcriptional Programs for Cell Proliferation and Invasiveness in Breast Cancer Cells
Jae-Hwan Kim et al.
CANCER RESEARCH (2014)
Loss of histone demethylase KDM6B enhances aggressiveness of pancreatic cancer through downregulation of C/EBPα
Keisuke Yamamoto et al.
CARCINOGENESIS (2014)
CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer
Edmond Chipumuro et al.
CELL (2014)
A 3D Map of the Human Genome at Kilobase Resolution Reveals Principles of Chromatin Looping
Suhas S. P. Rao et al.
CELL (2014)
Human UTY(KDM6C) Is a Male-specific Nε-Methyl Lysyl Demethylase
Louise J. Walport et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Inhibition of demethylases by GSK-J1/J4
Bo Heinemann et al.
NATURE (2014)
Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia
Panagiotis Ntziachristos et al.
NATURE (2014)
Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma
Rintaro Hashizume et al.
NATURE MEDICINE (2014)
The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes
Robert Huether et al.
NATURE COMMUNICATIONS (2014)
Quantitative ChIP-Seq Normalization Reveals Global Modulation of the Epigenome
David A. Orlando et al.
CELL REPORTS (2014)
biobambam: tools for read pair collation based algorithms on BAM files
German Tischler et al.
SOURCE CODE FOR BIOLOGY AND MEDICINE (2014)
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
Warren A. Whyte et al.
CELL (2013)
Super-Enhancers in the Control of Cell Identity and Disease
Denes Hnisz et al.
CELL (2013)
Dual CDK4/CDK6 Inhibition Induces Cell-Cycle Arrest and Senescence in Neuroblastoma
JulieAnn Rader et al.
CLINICAL CANCER RESEARCH (2013)
The histone demethylase Jmjd3 sequentially associates with the transcription factors Tbx3 and Eomes to drive endoderm differentiation
Apriliana E. R. Kartikasari et al.
EMBO JOURNAL (2013)
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth et al.
NATURE (2013)
Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position
Jason D. Buenrostro et al.
NATURE METHODS (2013)
Control of cell cycle transcription during G1 and S phases
Cosetta Bertoli et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
Alexandre Puissant et al.
CANCER DISCOVERY (2013)
Neuroblastoma: developmental biology, cancer genomics and immunotherapy
Nai-Kong V. Cheung et al.
NATURE REVIEWS CANCER (2013)
Copy Number Defects of G1-Cell Cycle Genes in Neuroblastoma are Frequent and Correlate with High Expression of E2F Target Genes and a Poor Prognosis
Jan J. Molenaar et al.
GENES CHROMOSOMES & CANCER (2012)
A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response
Laurens Kruidenier et al.
NATURE (2012)
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
Jan J. Molenaar et al.
NATURE (2012)
Histone Demethylase Jumonji D3 (JMJD3) as a Tumor Suppressor by Regulating p53 Protein Nuclear Stabilization
Chibawanye I. Ene et al.
PLOS ONE (2012)
Regulation of chromatin by histone modifications
Andrew J. Bannister et al.
CELL RESEARCH (2011)
Polycomb eviction as a new distant enhancer function
Douglas Vernimmen et al.
GENES & DEVELOPMENT (2011)
Integrative genomics viewer
James T. Robinson et al.
NATURE BIOTECHNOLOGY (2011)
BEDTools: a flexible suite of utilities for comparing genomic features
Aaron R. Quinlan et al.
BIOINFORMATICS (2010)
Mediator and cohesin connect gene expression and chromatin architecture
Michael H. Kagey et al.
NATURE (2010)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
Medical Progress: Recent Advances in Neuroblastoma.
John M. Maris
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Myc proteins as therapeutic targets
W. C. Gustafson et al.
ONCOGENE (2010)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
CTCF: Master Weaver of the Genome
Jennifer E. Phillips et al.
CELL (2009)
Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS
Marta Barradas et al.
GENES & DEVELOPMENT (2009)
The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence
Karl Agger et al.
GENES & DEVELOPMENT (2009)
MEME SUITE: tools for motif discovery and searching
Timothy L. Bailey et al.
NUCLEIC ACIDS RESEARCH (2009)
BRG1 requirement for long-range interaction of a locus control region with a downstream promoter
Shin-Il Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma
Jan J. Molenaar et al.
CANCER RESEARCH (2008)
Integration of external signaling pathways with the core transcriptional network in embryonic stem cells
Xi Chen et al.
CELL (2008)
Characterization of amplicons in neuroblastoma: High-resolution mapping using DNA microarrays, relationship with outcome, and identification of overexpressed genes
Anne Fix et al.
GENES CHROMOSOMES & CANCER (2008)
Ezh1 and Ezh2 Maintain Repressive Chromatin through Different Mechanisms
Raphael Margueron et al.
MOLECULAR CELL (2008)
Cohesin mediates transcriptional insulation by CCCTC-binding factor
Kerstin S. Wendt et al.
NATURE (2008)
Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data
M. Lastowska et al.
ONCOGENE (2007)
Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases
SunHwa Hong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination
Min Gyu Lee et al.
SCIENCE (2007)
UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development
Karl Agger et al.
NATURE (2007)
Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression
Yael P. Mosse et al.
GENES CHROMOSOMES & CANCER (2007)
The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing
Francesca De Santa et al.
CELL (2007)
TRANSFAC (R) and its module TRANSCompel (R): transcriptional gene regulation in eukaryotes
V. Matys et al.
NUCLEIC ACIDS RESEARCH (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Hligh-resolution detection, and mapping of genomic DNA alterations in neuroblastoma
YP Mosse et al.
GENES CHROMOSOMES & CANCER (2005)
Altered expression of cell cycle genes distinguishes aggressive neuroblastoma
AL Krasnoselsky et al.
ONCOGENE (2005)
Transcriptional regulation of AKT activation by E2F
M Chaussepied et al.
MOLECULAR CELL (2004)
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer
AP Bracken et al.
EMBO JOURNAL (2003)
E2F proteins regulate MYCN expression in neuroblastomas
V Strieder et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Myc requires distinct E2F activities to induce S phase and apoptosis
G Leone et al.
MOLECULAR CELL (2001)
Share Paper
